Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Manufacturing
Eli Lilly's Mounjaro, Zepbound supply outlook worsens
The FDA now expects most doses of the drugs to be in "limited availability" through the second quarter.
Zoey Becker
Apr 18, 2024 10:22am
Fujifilm Diosynth's restructuring may leave 240 out of work
Apr 17, 2024 12:10pm
Sponsored
Explore CDMOs' innovative solutions for cold chain needs
Apr 15, 2024 8:00am
Africa CDC slams Moderna after it halts Kenya plant buildout
Apr 17, 2024 10:28am
Kincell takes on Imugene's North Carolina plant, team for $6M
Apr 16, 2024 3:01pm
FDA slams 3 Indian drugmakers in flurry of recent Form 483s
Apr 16, 2024 8:45am